Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Share this article:
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Sponsors and Collaborators
Samsung Medical Center
Samsung Biomedical Research Institute

Contact
Kyu-Sung Lee, Ph.D    
82-2-3410-3554    
ksleedr@skku.edu

Principal Investigator
Kyu-Sung Lee, Ph.D, Samsung Medical Center

ClinicalTrials.gov Identifier
NCT01499069

Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Overactive Bladder Clinical Trials

Sign Up for Free e-newsletters

More in Overactive Bladder Clinical Trials

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the ...

A look at the following clinical trial: A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder.

Bladder Thermal Distention for Patients With Refractory Overactive Bladder (OAB)

A look at the following clinical trial: Bladder Thermal Distention for Patients With Refractory Overactive Bladder (OAB).

Peripheral Electrical Stimulation for the Treatment of Overactive Bladder (PESTOB)

A look at the following clinical trial: Peripheral Electrical Stimulation for the Treatment of Overactive Bladder (PESTOB).